Intrinsic value of PerkinElmer - PKI

Previous Close

$81.65

  Intrinsic Value

$102.66

stock screener

  Rating & Target

buy

+26%

Previous close

$81.65

 
Intrinsic value

$102.66

 
Up/down potential

+26%

 
Rating

buy

We calculate the intrinsic value of PKI stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 9.0

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  28.60
  26.24
  24.12
  22.20
  20.48
  18.94
  17.54
  16.29
  15.16
  14.14
  13.23
  12.41
  11.67
  11.00
  10.40
  9.86
  9.37
  8.94
  8.54
  8.19
  7.87
  7.58
  7.32
  7.09
  6.88
  6.69
  6.52
  6.37
  6.24
  6.11
Revenue, $m
  2,902
  3,664
  4,548
  5,558
  6,696
  7,964
  9,361
  10,886
  12,536
  14,309
  16,201
  18,211
  20,336
  22,572
  24,920
  27,377
  29,943
  32,618
  35,405
  38,304
  41,318
  44,451
  47,706
  51,089
  54,606
  58,261
  62,062
  66,017
  70,133
  74,420
Variable operating expenses, $m
  2,331
  2,829
  3,406
  4,066
  4,809
  5,638
  6,550
  7,546
  8,624
  9,783
  10,584
  11,898
  13,285
  14,747
  16,280
  17,885
  19,562
  21,310
  23,130
  25,024
  26,993
  29,040
  31,167
  33,377
  35,674
  38,062
  40,546
  43,129
  45,818
  48,619
Fixed operating expenses, $m
  44
  45
  46
  47
  48
  49
  50
  51
  52
  53
  55
  56
  57
  58
  60
  61
  62
  64
  65
  66
  68
  69
  71
  72
  74
  76
  77
  79
  81
  83
Total operating expenses, $m
  2,375
  2,874
  3,452
  4,113
  4,857
  5,687
  6,600
  7,597
  8,676
  9,836
  10,639
  11,954
  13,342
  14,805
  16,340
  17,946
  19,624
  21,374
  23,195
  25,090
  27,061
  29,109
  31,238
  33,449
  35,748
  38,138
  40,623
  43,208
  45,899
  48,702
Operating income, $m
  527
  791
  1,096
  1,445
  1,839
  2,277
  2,760
  3,288
  3,859
  4,472
  5,562
  6,258
  6,993
  7,768
  8,580
  9,430
  10,319
  11,245
  12,210
  13,213
  14,257
  15,341
  16,469
  17,640
  18,857
  20,123
  21,439
  22,809
  24,234
  25,719
EBITDA, $m
  1,047
  1,332
  1,664
  2,042
  2,469
  2,945
  3,469
  4,041
  4,660
  5,325
  6,035
  6,790
  7,587
  8,427
  9,308
  10,230
  11,193
  12,198
  13,243
  14,332
  15,463
  16,639
  17,862
  19,132
  20,452
  21,824
  23,252
  24,737
  26,282
  27,892
Interest expense (income), $m
  31
  108
  163
  229
  304
  391
  489
  597
  717
  848
  989
  1,141
  1,304
  1,476
  1,658
  1,850
  2,051
  2,262
  2,482
  2,711
  2,950
  3,198
  3,457
  3,725
  4,004
  4,294
  4,596
  4,909
  5,235
  5,574
  5,927
Earnings before tax, $m
  419
  627
  867
  1,141
  1,448
  1,789
  2,163
  2,571
  3,011
  3,483
  4,421
  4,954
  5,517
  6,110
  6,730
  7,380
  8,057
  8,763
  9,499
  10,263
  11,058
  11,885
  12,743
  13,636
  14,563
  15,527
  16,530
  17,574
  18,660
  19,791
Tax expense, $m
  113
  169
  234
  308
  391
  483
  584
  694
  813
  940
  1,194
  1,338
  1,490
  1,650
  1,817
  1,992
  2,175
  2,366
  2,565
  2,771
  2,986
  3,209
  3,441
  3,682
  3,932
  4,192
  4,463
  4,745
  5,038
  5,344
Net income, $m
  306
  458
  633
  833
  1,057
  1,306
  1,579
  1,877
  2,198
  2,543
  3,227
  3,617
  4,028
  4,460
  4,913
  5,387
  5,882
  6,397
  6,934
  7,492
  8,073
  8,676
  9,303
  9,954
  10,631
  11,335
  12,067
  12,829
  13,622
  14,448

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  7,823
  9,876
  12,258
  14,980
  18,048
  21,466
  25,231
  29,341
  33,789
  38,568
  43,670
  49,087
  54,813
  60,842
  67,169
  73,791
  80,708
  87,920
  95,430
  103,244
  111,369
  119,813
  128,588
  137,707
  147,185
  157,038
  167,284
  177,944
  189,039
  200,592
Adjusted assets (=assets-cash), $m
  7,823
  9,876
  12,258
  14,980
  18,048
  21,466
  25,231
  29,341
  33,789
  38,568
  43,670
  49,087
  54,813
  60,842
  67,169
  73,791
  80,708
  87,920
  95,430
  103,244
  111,369
  119,813
  128,588
  137,707
  147,185
  157,038
  167,284
  177,944
  189,039
  200,592
Revenue / Adjusted assets
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
  0.371
Average production assets, $m
  2,543
  3,210
  3,984
  4,868
  5,866
  6,976
  8,200
  9,536
  10,981
  12,534
  14,192
  15,953
  17,814
  19,774
  21,830
  23,982
  26,230
  28,574
  31,014
  33,554
  36,194
  38,939
  41,791
  44,754
  47,834
  51,037
  54,367
  57,831
  61,437
  65,192
Working capital, $m
  340
  429
  532
  650
  783
  932
  1,095
  1,274
  1,467
  1,674
  1,896
  2,131
  2,379
  2,641
  2,916
  3,203
  3,503
  3,816
  4,142
  4,482
  4,834
  5,201
  5,582
  5,977
  6,389
  6,817
  7,261
  7,724
  8,206
  8,707
Total debt, $m
  3,026
  4,235
  5,638
  7,241
  9,048
  11,061
  13,279
  15,700
  18,319
  21,134
  24,139
  27,330
  30,703
  34,254
  37,981
  41,881
  45,955
  50,203
  54,626
  59,229
  64,014
  68,988
  74,156
  79,527
  85,110
  90,913
  96,948
  103,227
  109,762
  116,567
Total liabilities, $m
  4,608
  5,817
  7,220
  8,823
  10,630
  12,643
  14,861
  17,282
  19,902
  22,716
  25,721
  28,912
  32,285
  35,836
  39,563
  43,463
  47,537
  51,785
  56,208
  60,811
  65,596
  70,570
  75,738
  81,109
  86,692
  92,495
  98,530
  104,809
  111,344
  118,149
Total equity, $m
  3,215
  4,059
  5,038
  6,157
  7,418
  8,822
  10,370
  12,059
  13,887
  15,851
  17,948
  20,175
  22,528
  25,006
  27,607
  30,328
  33,171
  36,135
  39,222
  42,433
  45,773
  49,243
  52,850
  56,598
  60,493
  64,542
  68,754
  73,135
  77,695
  82,443
Total liabilities and equity, $m
  7,823
  9,876
  12,258
  14,980
  18,048
  21,465
  25,231
  29,341
  33,789
  38,567
  43,669
  49,087
  54,813
  60,842
  67,170
  73,791
  80,708
  87,920
  95,430
  103,244
  111,369
  119,813
  128,588
  137,707
  147,185
  157,037
  167,284
  177,944
  189,039
  200,592
Debt-to-equity ratio
  0.940
  1.040
  1.120
  1.180
  1.220
  1.250
  1.280
  1.300
  1.320
  1.330
  1.340
  1.350
  1.360
  1.370
  1.380
  1.380
  1.390
  1.390
  1.390
  1.400
  1.400
  1.400
  1.400
  1.410
  1.410
  1.410
  1.410
  1.410
  1.410
  1.410
Adjusted equity ratio
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411
  0.411

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  306
  458
  633
  833
  1,057
  1,306
  1,579
  1,877
  2,198
  2,543
  3,227
  3,617
  4,028
  4,460
  4,913
  5,387
  5,882
  6,397
  6,934
  7,492
  8,073
  8,676
  9,303
  9,954
  10,631
  11,335
  12,067
  12,829
  13,622
  14,448
Depreciation, amort., depletion, $m
  520
  542
  568
  597
  630
  667
  708
  753
  801
  853
  473
  532
  594
  659
  728
  799
  874
  952
  1,034
  1,118
  1,206
  1,298
  1,393
  1,492
  1,594
  1,701
  1,812
  1,928
  2,048
  2,173
Funds from operations, $m
  826
  1,000
  1,201
  1,430
  1,687
  1,973
  2,287
  2,629
  2,999
  3,395
  3,700
  4,149
  4,622
  5,119
  5,641
  6,186
  6,756
  7,350
  7,968
  8,611
  9,279
  9,974
  10,696
  11,446
  12,225
  13,036
  13,879
  14,756
  15,670
  16,621
Change in working capital, $m
  76
  89
  103
  118
  133
  148
  163
  178
  193
  207
  221
  235
  249
  262
  275
  287
  300
  313
  326
  339
  353
  367
  381
  396
  411
  428
  445
  463
  482
  501
Cash from operations, $m
  750
  911
  1,097
  1,312
  1,554
  1,825
  2,124
  2,451
  2,806
  3,188
  3,479
  3,913
  4,373
  4,857
  5,366
  5,899
  6,456
  7,037
  7,642
  8,272
  8,927
  9,607
  10,315
  11,050
  11,814
  12,608
  13,434
  14,294
  15,188
  16,119
Maintenance CAPEX, $m
  -66
  -85
  -107
  -133
  -162
  -196
  -233
  -273
  -318
  -366
  -418
  -473
  -532
  -594
  -659
  -728
  -799
  -874
  -952
  -1,034
  -1,118
  -1,206
  -1,298
  -1,393
  -1,492
  -1,594
  -1,701
  -1,812
  -1,928
  -2,048
New CAPEX, $m
  -566
  -667
  -774
  -885
  -997
  -1,111
  -1,224
  -1,336
  -1,446
  -1,553
  -1,658
  -1,761
  -1,861
  -1,959
  -2,056
  -2,152
  -2,248
  -2,344
  -2,441
  -2,539
  -2,640
  -2,744
  -2,852
  -2,964
  -3,080
  -3,202
  -3,330
  -3,464
  -3,606
  -3,755
Cash from investing activities, $m
  -632
  -752
  -881
  -1,018
  -1,159
  -1,307
  -1,457
  -1,609
  -1,764
  -1,919
  -2,076
  -2,234
  -2,393
  -2,553
  -2,715
  -2,880
  -3,047
  -3,218
  -3,393
  -3,573
  -3,758
  -3,950
  -4,150
  -4,357
  -4,572
  -4,796
  -5,031
  -5,276
  -5,534
  -5,803
Free cash flow, $m
  118
  159
  216
  294
  394
  519
  668
  842
  1,043
  1,269
  1,403
  1,680
  1,980
  2,304
  2,651
  3,019
  3,409
  3,819
  4,249
  4,698
  5,168
  5,656
  6,165
  6,693
  7,242
  7,812
  8,403
  9,017
  9,655
  10,317
Issuance/(repayment) of debt, $m
  1,020
  1,209
  1,403
  1,603
  1,807
  2,013
  2,218
  2,421
  2,620
  2,815
  3,005
  3,191
  3,373
  3,551
  3,727
  3,900
  4,074
  4,248
  4,424
  4,602
  4,785
  4,974
  5,169
  5,371
  5,582
  5,803
  6,035
  6,279
  6,535
  6,805
Issuance/(repurchase) of shares, $m
  406
  386
  346
  286
  204
  99
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  1,426
  1,595
  1,749
  1,889
  2,011
  2,112
  2,218
  2,421
  2,620
  2,815
  3,005
  3,191
  3,373
  3,551
  3,727
  3,900
  4,074
  4,248
  4,424
  4,602
  4,785
  4,974
  5,169
  5,371
  5,582
  5,803
  6,035
  6,279
  6,535
  6,805
Total cash flow (excl. dividends), $m
  1,544
  1,754
  1,965
  2,183
  2,406
  2,630
  2,885
  3,263
  3,662
  4,084
  4,408
  4,871
  5,353
  5,855
  6,377
  6,920
  7,482
  8,066
  8,672
  9,301
  9,953
  10,630
  11,333
  12,064
  12,824
  13,615
  14,438
  15,296
  16,190
  17,121
Retained Cash Flow (-), $m
  -712
  -844
  -979
  -1,119
  -1,261
  -1,405
  -1,548
  -1,689
  -1,828
  -1,964
  -2,097
  -2,227
  -2,353
  -2,478
  -2,600
  -2,722
  -2,843
  -2,964
  -3,087
  -3,211
  -3,339
  -3,471
  -3,607
  -3,748
  -3,895
  -4,050
  -4,211
  -4,381
  -4,560
  -4,748
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  832
  910
  986
  1,065
  1,145
  1,226
  1,338
  1,574
  1,834
  2,119
  2,311
  2,644
  3,000
  3,377
  3,777
  4,198
  4,640
  5,102
  5,585
  6,089
  6,614
  7,160
  7,727
  8,316
  8,929
  9,566
  10,227
  10,915
  11,629
  12,373
Discount rate, %
  7.20
  7.56
  7.94
  8.33
  8.75
  9.19
  9.65
  10.13
  10.64
  11.17
  11.73
  12.31
  12.93
  13.58
  14.26
  14.97
  15.72
  16.50
  17.33
  18.19
  19.10
  20.06
  21.06
  22.11
  23.22
  24.38
  25.60
  26.88
  28.22
  29.64
PV of cash for distribution, $m
  776
  787
  784
  773
  753
  723
  702
  727
  738
  735
  682
  656
  617
  568
  512
  451
  388
  326
  268
  215
  168
  128
  95
  69
  48
  33
  22
  14
  9
  5
Current shareholders' claim on cash, %
  95.7
  92.6
  90.5
  89.1
  88.3
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0
  88.0

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. It provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. Its products include AAnalyst, Altus, Aquamatic, Avio, AxION, Clarus, DairyGuard, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, Cell carrier and cell::explorer. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. Its products include AutoDELFIA, BACS-on-Beads, Bioo Scientific, BoBs, Datalytix, Dexela, Dexela CMOS FPDs, Evolution, ViaCord, and Zephyr.

FINANCIAL RATIOS  of  PerkinElmer (PKI)

Valuation Ratios
P/E Ratio 38.2
Price to Sales 4.2
Price to Book 4.2
Price to Tangible Book
Price to Cash Flow 25.5
Price to Free Cash Flow 28.1
Growth Rates
Sales Growth Rate 0.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 14.3%
Cap. Spend. - 3 Yr. Gr. Rate -3.9%
Financial Strength
Quick Ratio 359
Current Ratio 0.3
LT Debt to Equity 48.5%
Total Debt to Equity 48.6%
Interest Coverage 9
Management Effectiveness
Return On Assets 6.2%
Ret/ On Assets - 3 Yr. Avg. 5.5%
Return On Total Capital 7.4%
Ret/ On T. Cap. - 3 Yr. Avg. 6.5%
Return On Equity 11%
Return On Equity - 3 Yr. Avg. 9.7%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 47.9%
Gross Margin - 3 Yr. Avg. 46.2%
EBITDA Margin 17.7%
EBITDA Margin - 3 Yr. Avg. 16%
Operating Margin 13.4%
Oper. Margin - 3 Yr. Avg. 11.6%
Pre-Tax Margin 11.5%
Pre-Tax Margin - 3 Yr. Avg. 9.7%
Net Profit Margin 11.1%
Net Profit Margin - 3 Yr. Avg. 9.4%
Effective Tax Rate 11.5%
Eff/ Tax Rate - 3 Yr. Avg. 8.8%
Payout Ratio 13.2%

PKI stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the PKI stock intrinsic value calculation we used $2256.982 million for the last fiscal year's total revenue generated by PerkinElmer. The default revenue input number comes from 0001 income statement of PerkinElmer. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our PKI stock valuation model: a) initial revenue growth rate of 28.6% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.2%, whose default value for PKI is calculated based on our internal credit rating of PerkinElmer, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of PerkinElmer.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of PKI stock the variable cost ratio is equal to 84.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $43 million in the base year in the intrinsic value calculation for PKI stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for PerkinElmer.

Corporate tax rate of 27% is the nominal tax rate for PerkinElmer. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the PKI stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for PKI are equal to 87.6%.

Life of production assets of 35.5 years is the average useful life of capital assets used in PerkinElmer operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for PKI is equal to 11.7%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2503.188 million for PerkinElmer - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 110.734 million for PerkinElmer is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of PerkinElmer at the current share price and the inputted number of shares is $9.0 billion.

RELATED COMPANIES Price Int.Val. Rating
TMO Thermo Fisher 237.69 199.97  hold
HBIO Harvard Biosci 3.73 0.23  str.sell
BRKR Bruker 32.16 23.13  sell
WAT Waters 198.07 78.64  str.sell
A Agilent Techno 64.72 100.49  str.buy
BIO Bio-Rad Labora 273.22 323.94  hold
MTD Mettler-Toledo 592.44 451.96  sell

COMPANY NEWS

▶ PerkinElmer: 3Q Earnings Snapshot   [04:32PM  Associated Press]
▶ PerkinElmer Board Declares Quarterly Dividend   [Oct-24-18 04:15PM  Business Wire]
▶ Nasdaq Loses Early Luster; This Top Growth Stock Faces Key Test Of Support   [Oct-09-18 02:25PM  Investor's Business Daily]
▶ How This Player Helps Medical Researchers Ease Drug Discovery Process   [Sep-06-18 12:33PM  Investor's Business Daily]
▶ Earnings winners...and losers in the blitz   [Aug-30-18 02:13PM  CNBC Videos]
▶ PerkinElmer Made an Upside Breakout, Time to Go Long   [Aug-07-18 10:23AM  TheStreet.com]
▶ Should You Buy Apple Now? Plus, A Look At 4 Other Bullish Charts   [Aug-05-18 06:04PM  Investor's Business Daily]
▶ PerkinElmer: 2Q Earnings Snapshot   [04:37PM  Associated Press]
▶ PerkinElmer Board Declares Quarterly Dividend   [Jul-23-18 04:15PM  Business Wire]
▶ Should You Buy PerkinElmer Inc (NYSE:PKI) Now?   [Jun-21-18 08:01AM  Simply Wall St.]
▶ PerkinElmer: 1Q Earnings Snapshot   [04:25PM  Associated Press]
▶ PerkinElmer, Inc. to Host Earnings Call   [01:00PM  ACCESSWIRE]
▶ PerkinElmer Board Declares Quarterly Dividend   [Apr-26-18 04:15PM  Business Wire]
▶ PerkinElmer Appoints James Mock as Chief Financial Officer   [Apr-10-18 04:30PM  Business Wire]
▶ PerkinElmer to Hold Earnings Call on Monday, April 30, 2018   [Apr-06-18 04:34PM  Business Wire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.